Literature DB >> 12098736

Insulin pumps are still debatable for type 1 diabetes.

J Hans DeVries, Robert J Heine.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12098736      PMCID： PMC1123559          DOI： 10.1136/bmj.325.7354.46

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes.

Authors:  P Raskin; R A Guthrie; L Leiter; A Riis; L Jovanovic
Journal:  Diabetes Care       Date:  2000-05       Impact factor: 19.112

2.  Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials.

Authors:  John Pickup; Martin Mattock; Sally Kerry
Journal:  BMJ       Date:  2002-03-23

3.  Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

Authors:  P D Home; A Lindholm; A Riis
Journal:  Diabet Med       Date:  2000-11       Impact factor: 4.359

4.  Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection.

Authors:  E Tsui; A Barnie; S Ross; R Parkes; B Zinman
Journal:  Diabetes Care       Date:  2001-10       Impact factor: 19.112

5.  Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion.

Authors:  M L Reeves; D E Seigler; E A Ryan; J S Skyler
Journal:  Am J Med       Date:  1982-04       Impact factor: 4.965
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.